Peter Reynolds This Photo by Unknown Author is licensed under CC BY-SA.

Slides:



Advertisements
Similar presentations
Division: EIDD WTO TBT Workshop on Good Regulatory Practice March 2008 Focus on Transparency and Consultation.
Advertisements

London Medicines Information Service (Northwick Park Hospital) - June 2008 Drug Promotion: The Pharmaceutical Representative. Making the most of Promotional.
SAFE. SENSIBLE. SOCIAL. A NEW CODE OF PRACTICE FOR ALCOHOL RETAILERS Mark Cooper SAFE. SENSIBLE. SOCIAL. A NEW CODE OF PRACTICE FOR ALCOHOL RETAILERS Mark.
From POM to P From POM to P Wellard’s NHS training wellards.co.uk 2004.
The Micro Criteria Regulation – what does it all mean? Kaarin Goodburn CSci FIFST MSc BSc Food Safety & Technology Management Consultant Chilled Food Association:
April 2010 – An Opportunity for the Herbal Industry Jonathan Griffith.
Marihuana for Medical Purposes A New Approach. History of Access to Marihuana for Medical Purposes R. v. Parker (Ontario Court of Appeal 2000) The facts.
Governing Pharmaceutical Technologies in the Age of the Internet Nick Fox, Katie Ward and Alan O’Rourke University of Sheffield, UK.
Big Pharma / THE FACTS New Internationalist 362, November 2003.
OPPORTUNITIES AND THREATS FOR STARCH EUROPE
Consumer Protection Act By Emily Gilks. About the act The consumer protection act The act is in place to protect the public in the following ways:
Promotional Material & The Pharmaceutical Representative. Bridget Rankin, Principal Pharmacist – Medicines Information Maidstone & Tunbridge Wells NHS.
Unlicensed Medicines in Paediatrics Is there a problem ? Scottish Neonatal and Paediatric Pharmacist Group National Paediatric Pre- Registration Pharmacist.
Medico-legal aspects of “off-licence” prescribing in Obstetrics ENTER 2006 CONFERENCE Saj Shah Solicitor/Pharmacist 3 May 2006.
What the government does A2 Economics and Business Unit 4B By Mrs Hilton for revisionstation.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
Graham Bartlett Policy Director SITPRO Ltd UK Experience of Implementing WCO SAFE Framework of Standards.
Family Planning Policy in China Wenxin Huang January 22 nd 2011.
UK Government timber procurement policy Marigold Norman Department for Environment, Food, and Rural Affairs National Sustainable Procurement Stakeholder.
Amendment 64 Use and Regulation of Marijuana THE PEOPLE OF THE STATE OF COLORADO FIND AND DECLARE THAT  MARIJUANA SHOULD BE LEGAL FOR PERSONS TWENTY-ONE.
PEOPLE RESOURCING Chapter Four The Regulatory Environment.
IHTA 2007 AGM LEGISLATION & REGULATION Top 15 Threats & Action Underway.
Codes of Conduct The International Pharmaceutical Regulatory & Compliance Congress and Best Practice Forum 6 June 2007 Heather Simmonds Director Prescription.
E UROPEAN B LOOD D IRECTIVE. D ISCLAIMER I have no official status as a spokesperson for the EU, EC, or Member States I present a personal view of the.
27J: Recognize the importance and influence of special interest groups and lobbyists on the legislative process, understanding the purpose and function.
Introduction 2 Boris Shcharansky Founder/CEO of Heartland Hemp Company in Des Moines, IA Entrepreneur and Hemp Advocate Eight years of direct business.
2 The Republic of Ireland and Northern Ireland #mabal2016.
An internal market perspective on medical services Jarek Pytko E2 - Public Interest Services DG for Internal Market, Industry, Entrepreneurship & SMEs.
1 Bolar Provisions in Europe Robert Watson Chartered Patent Attorney European Patent Attorney AIPLA, February 2006.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
The Economic Environment of Business – Lecture 5 Competition Policy.
1 Improving the agenda for SWITCH for nonprescription Medicines Sheila Kelly WSMI September 2015.
GLOBALG.A.P. Risk Assessment On Social Practice
Off-label Use.
Proposition 64 County Behavioral Health Directors Association
Potential Local Impacts from Proposition 64 and Measure L
Interest Groups.
Lesson Objectives All students will understand the importance of regulation in some markets Most students will be able to assess the why the regulation.
Working Around Federal Marijuana Law Professor Robert A. Mikos
Patent law update.
Medical cannabis availability in Central & Eastern Europe
Proposition 64 County Behavioral Health Directors Association
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Career Pictures.
Prescription for Pharmaceutical Reform: Healing an Ailing System
LEGAL IMPLICATIONS: Workers using their own vehicles for work purposes.
Medicinal Cannabis Reform Workshop
GDPR General Data Protection Regulation EU: Coming May 25, 2018
Drugs prohibition is criminals’ gain, neuroscience’s loss
Nuk’way’ln Hall Community and Youth 5:30 – 7:30
Intellectual property and design: safeguarding the future
Drugs prohibition is criminals’ gain, neuroscience’s loss
Canada West vs Canada East
Organisations that protect the interests of consumers
Medicinal cannabis policies and practices around the world
Intellectual property Brexit – future proofing IP
Texting & Talking while driving survey results are as follows:
Raising the Standards in European Homeopathy
Supply & Demand.
Trade barriers.
AT&T 2:03 November 03
ANCIENT GREECE BY- MAEVE MCGRATH.
Industrial Hemp Primer
Prescribing in Practice Part 1 (b)
Responsibilities of a Manager
Calculating Angles This Photo by Unknown Author is licensed under CC BY-SA-NC This Photo by Unknown Author is licensed under CC BY This Photo by Unknown.
Book Report Non- Fiction Text.
THE DYNAMIC REGULATORY ENVIRONMENT
Access to Cannabis for Medicinal and Research Purposes
ADVOCATING FOR CHILDREN & YOUTH: IMPLICATIONS FOR CASA VOLUNTEERS
Presentation transcript:

Peter Reynolds This Photo by Unknown Author is licensed under CC BY-SA

Founded 1999 Approx 750,000 followers 5,000 paid members Peter Reynolds Founded 1999 Approx 750,000 followers 5,000 paid members This Photo by Unknown Author is licensed under CC BY-SA

The trade association for the UK’s cannabis, CBD and hemp businesses Peter Reynolds The trade association for the UK’s cannabis, CBD and hemp businesses This Photo by Unknown Author is licensed under CC BY-SA

To end the prohibition of cannabis. Aims and Objectives To end the prohibition of cannabis. To promote as a matter of urgency and compassion the prescription of medicinal cannabis by doctors. To introduce a system of regulation for the production and supply of cannabis based on facts and evidence. To encourage the production and use of industrial hemp. To educate and inform about the uses and benefits of cannabis. This Photo by Unknown Author is licensed under CC BY-SA

The UK’s Legal Cannabis Industry Cultivated for millennia. As common on the land as wheat or barley 1928 Cannabis possession banned 1964 Cannabis cultivation banned 1993 Industrial hemp licensing introduced 2010 Sativex granted marketing authorisation 2012 Start of the CBD industry 2018 CBPMs defined and placed in schedule 2 This Photo by Unknown Author is licensed under CC BY-SA

The UK’s CBD Industry How to enjoy medicinal benefits of cannabis legally Now worth at least £50 million pa Major driver of cannabis law reform Major influence on the 2018 medical access reform Destigmatising cannabis This Photo by Unknown Author is licensed under CC BY-SA

YET The UK’s CBD Industry Must not make claims of medicinal benefit for CBD products YET Virtually all CBD products are bought for medicinal purposes This Photo by Unknown Author is licensed under CC BY-SA

The UK’s CBD Industry Justified intervention from MHRA Opposition from medical establishment Opposition from big business establishment Threat to pharmaceutical industry Unjustified intervention from FSA Bureaucrats responding to lobbying by vested interests This Photo by Unknown Author is licensed under CC BY-SA

FSA Intervention Novel foods legislation is about safety FSA has no evidence CBD products are unsafe WHO has unequivocally declared CBD safe Intervention made surreptitiously through EU when UK is on the brink of Brexit This Photo by Unknown Author is licensed under CC BY-SA

This is something that really needs doing! If bureaucrats have so much time on their hands, why not start on the regulation of the £6 billion criminal cannabis market? This is something that really needs doing! This Photo by Unknown Author is licensed under CC BY-SA

Why Cannabis Professionals? MHRA intervention CLEAR forced MHRA response Creation of Cannabis Trades Association Two years intensive work as part of CTA This Photo by Unknown Author is licensed under CC BY-SA

Why Cannabis Professionals? Resignation from CTA Love Hemp resignation from CTA Aim to support and nurture the industry without exploiting it This Photo by Unknown Author is licensed under CC BY-SA

No membership fees at present One-off £120 application fee for CannaPro Certification All advice and guidance published openly Inclusive not exclusive Co-operative advertising campaign This Photo by Unknown Author is licensed under CC BY-SA

Why Cannabis Professionals? Follow CannaPro for all the latest news CannaPro represents the industry to the authorities, not vice versa This Photo by Unknown Author is licensed under CC BY-SA

Why Cannabis Professionals? A balance, sensible approach to compliance Future development of CBPMs, THR and VMD licensed products This Photo by Unknown Author is licensed under CC BY-SA

Long term objective – to close down CLEAR Peter Reynolds Long term objective – to close down CLEAR This Photo by Unknown Author is licensed under CC BY-SA

THE END When adults have legal access to cannabis for all purposes, including the right to grow it for themselves. This Photo by Unknown Author is licensed under CC BY-SA